Documentos de Stevenson J.C. | REDI

Regresar

Mostrando 8 resultados de: 8

Filtros aplicados

Área temáticas: "Ginecología, obstetricia, pediatría, geriatría"

Subtipo de publicación

Publisher

Área temáticas

Enfermedades(3)

Salud y seguridad personal(3)

Fisiología humana(2)

Medicina y salud(2)

Farmacología y terapéutica(1)

Área de conocimiento

Ginecología(3)

Medicina interna(1)

Año de Publicación

Origen

Palabras Claves

OSTEOPOROSIS(2)

Aromatase inhibitors(1)

A model of care for healthy menopause and ageing: EMAS position statement

Abstract: Worldwide, the number of menopausal women is increasing. They present with complex medical issues th

Palabras claves:

EMAS, Healthcare model, Healthy menopause, Holistic, Women's health

Ceausu I., Depypere H., Faustino R. Pérez-López, Lambrinoudaki I., Mueck A., Rees M., Senturk L.M., Simoncini T., Stevenson J.C., Stute P., van der Schouw Y.T.

Current management of pelvic organ prolapse in aging women: EMAS clinical guide

Abstract: Management of pelvic organ prolapse (POP) is a common and challenging task. Nowadays older women are

Palabras claves:

aging, management, Pelvic organ prolapse, Urinary incontinence

Cano A., Giannini A., Goulis D.G., Lambrinoudaki I., Lopes P., Mishra G.D., Mueck A., Peter A. Chedraui, Rees M., Russo E., Senturk L.M., Simoncini T., Stevenson J.C., Stute P., Tuomikoski P.

EMAS position statement: Pbkp_redictors of premature and early natural menopause

Abstract: Introduction: While the associations of genetic, reproductive and environmental factors with the tim

Palabras claves:

Aetiology, Early menopause, Premature ovarian insufficiency, RISK FACTORS

Cano A., Chung H.F., Goulis D.G., Lambrinoudaki I., Lopes P., Mishra G.D., Mueck A., Peter A. Chedraui, Rees M., Senturk L.M., Simoncini T., Stevenson J.C., Stute P., Tuomikoski P.

EMAS position statement: Testosterone replacement therapy in the aging male

Abstract: Introduction Late-onset hypogonadism (LOH) represents a common clinical entity in aging males, chara

Palabras claves:

Aging male, Late-onset hypogonadism, Testosterone replacement

Ceausu I., Depypere H., Dimopoulou C., Faustino R. Pérez-López, Goulis D.G., Lambrinoudaki I., Mueck A., Rees M., Senturk L.M., Simonsini T., Stevenson J.C., Stute P., van der Schouw Y.T.

Osteoporosis management in patients with breast cancer: EMAS position statement

Abstract: Aromatase inhibitors (AIs) are the first-line recommended standard of care for postmenopausal estrog

Palabras claves:

adjuvant therapy, Aromatase inhibitors, Bisphosphonates, Breast Cancer, Denosumab, fractures, OSTEOPOROSIS, screening

Ceausu I., Depypere H., Faustino R. Pérez-López, Lambrinoudaki I., Mueck A., Rees M., Senturk L.M., Simoncini T., Stevenson J.C., Stute P., Trémollieres F.A., van der Schouw Y.T.

Maintaining postreproductive health: A care pathway from the European Menopause and Andropause Society (EMAS)

Abstract: This position statement from the European Menopause and Andropause Society (EMAS) provides a care pa

Palabras claves:

genitourinary syndrome of menopause, hormone therapy, Hot Flushes, MENOPAUSE, OSTEOPOROSIS, Women

Armeni E., Ceausu I., Depypere H., Faustino R. Pérez-López, Lambrinoudaki I., Mueck A., Rees M., Schouw Y.T.V.D., Senturk L.M., Simoncini T., Stevenson J.C., Stute P.

Interventions to reduce the risk of ovarian and fallopian tube cancer: A European Menopause and Andropause Society Postition Statement

Abstract: Background Ovarian cancer is a leading cause of female gynecological cancer-related death, and there

Palabras claves:

bilateral oophorectomy, Bilateral salpingectomy, BRCA gene mutation, Combined oral contraceptives, Fallopian tubes cancer, hysterectomy, Non-steroid anti-inflammatory drugs, obesity, Ovarian borderline tumors, Ovarian Cancer, smoking

Ceausu I., Depypere H., Faustino R. Pérez-López, Kehoe S., Lambrinoudaki I., Mueck A., Rees M., Senturk L.M., Simoncini T., Stevenson J.C., Stute P.

Menopause and diabetes: EMAS clinical guide

Abstract: Introduction: Whether menopause increases the risk of type 2 diabetes mellitus (T2DM) independently

Palabras claves:

menopausal hormone therapy, MENOPAUSE, Type 2 Diabetes mellitus

Anagnostis P., Cano A., Goulis D.G., Jaremek J.D., Lambrinoudaki I., Lopes P., Meczekalski B., Mishra G.D., Mueck A., Paschou S.A., Peter A. Chedraui, Rees M., Rogowicz-Frontczak A., Senturk L.M., Simoncini T., Slopien R., Stevenson J.C., Stute P., Tuomikoski P., Wender-Ozegowska E., Zozulinska-Ziolkiewicz D.